Labcorp Partners with Roche to Expand Digital Pathology and Advance AI Integration in Diagnostics
Labcorp Holdings Inc. has announced a collaboration with Roche to advance digital pathology capabilities across its diagnostics and biopharma laboratory services. Through this partnership, Labcorp will implement Roche's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners, enabling pathologists to diagnose patients using digital images and supporting future integration of artificial intelligence. The initiative is designed to improve diagnostic accuracy, streamline operations, and facilitate efficient data sharing and centralized review, particularly in the face of a projected shortage of pathologists in the U.S. This collaboration builds on Labcorp's ongoing relationship with Roche and aims to enhance patient care through innovative technology solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC86578) on September 30, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。